InvestSMART

Atomo Diagnostics Limited (ASX: AT1) - Announcements

Current share price for AT1 : $0.016 0.001 (3.03%)+

ASX company news and announcements for Atomo Diagnostics Limited (AT1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Atomo Diagnostics Limited (AT1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Atomo Diagnostics Limited (AT1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Atomo Diagnostics Limited (AT1)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$14 Proposed issue of Securities - AT1 30 Apr 2021 12:45PM $0.215 $0.016 fallen by 92.56%
$14 Update to Atomo's US market strategy 30 Apr 2021 12:33PM $0.215 $0.016 fallen by 92.56%
$14 Quarterly Activity Report & Appendix 4C - 31 March 2021 30 Apr 2021 12:20PM $0.210 $0.016 fallen by 92.38%
$14 Viatris & Atomo to Support Unitaid HIV Self-Test Expansion 29 Apr 2021 8:47AM $0.205 $0.016 fallen by 92.20%
$14 Appendix 3Y - C LaBelle 9 Apr 2021 1:21PM $0.240 $0.016 fallen by 93.33%
$14 Cleansing notice 9 Apr 2021 9:27AM $0.240 $0.016 fallen by 93.33%
$14 Appendix 3G 8 Apr 2021 10:45AM $0.255 $0.016 fallen by 93.73%
$14 Appendix 2A 8 Apr 2021 10:40AM $0.245 $0.016 fallen by 93.47%
$14 Atomo to present at NWR Virtual Investor Conference 17 Mar 2021 5:06PM $0.270 $0.016 fallen by 94.07%
$14 S&P DJI Announces March 2021 Quarterly Rebalance 12 Mar 2021 5:02PM $0.280 $0.016 fallen by 94.29%
$14 Investor Presentation 10 Mar 2021 9:09AM $0.235 $0.016 fallen by 93.19%
$14 Notification of release of escrowed shares 8 Mar 2021 10:00AM $0.240 $0.016 fallen by 93.33%
$14 Investor Presentation 23 Feb 2021 9:47AM $0.275 $0.016 fallen by 94.18%
$14 Appendix 4D and Half Year Financial Report 23 Feb 2021 9:44AM $0.275 $0.016 fallen by 94.18%
$14 H1 FY21 results investor briefing 19 Feb 2021 3:35PM $0.280 $0.016 fallen by 94.29%
$14 Quarterly Activity Report & Appendix 4C - 31 December 2020 27 Jan 2021 10:40AM $0.300 $0.016 fallen by 94.67%
$14 Atomo provides update on its HIV Rapid Test business 7 Dec 2020 9:49AM $0.320 $0.016 fallen by 95%
$14 Cleansing notice 26 Nov 2020 7:11PM $0.325 $0.016 fallen by 95.08%
$14 Appendix 3G 26 Nov 2020 5:38PM $0.325 $0.016 fallen by 95.08%
$14 Appendix 2A 25 Nov 2020 11:46AM $0.330 $0.016 fallen by 95.15%
$14 Cleansing notice 19 Nov 2020 12:31PM $0.325 $0.016 fallen by 95.08%
$14 Appendix 2A 18 Nov 2020 11:16AM $0.325 $0.016 fallen by 95.08%
$14 Atomo receives TGA approval for AtomoRapid HIV (1&2) test 10 Nov 2020 8:21AM $0.340 $0.016 fallen by 95.29%
$14 Results of the AGM 4 Nov 2020 4:23PM $0.345 $0.016 fallen by 95.36%
$14 Managing Director's AGM Presentation 4 Nov 2020 9:30AM $0.330 $0.016 fallen by 95.15%

301 - 325 of 398 results

Page 13 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.